Educational pathophysiology diagram comparing splenic tissue responses during dual parasitic and bacterial co-infections in a rodent model. Panel A illustrates Plasmodium chabaudi and Salmonella typhimurium co-infection, showing preserved splenic architecture. Key features include an intact white pulp (WP) with visible periarteriolar lymphoid sheaths (PALS) and B cell follicles, a functional marginal zone (MZ) containing MZ B cells and dendritic cells (DC), and infected red blood cells (iRBC) localized in the red pulp (RP). Panel B depicts Leishmania donovani and Streptococcus pneumoniae co-infection characterized by significant atrophy of the white pulp and marginal zone. In this state, L. donovani amastigotes are seen phagocytosed within large numbers of red pulp macrophages (MØ). Due to the lack of a functional marginal zone, S. pneumoniae bacteria are redistributed to the red pulp. Anatomical landmarks labeled include the central arteriole (CA) and venous sinuses (VS). This comparison demonstrates how different parasitic infections can either preserve or disrupt the spleen's immunological compartments and its subsequent capacity to manage secondary bacterial invasions.

This Comparison Chart illustrates cytokine response patterns in human peripheral blood mononuclear cells (PBMCs) across various stimuli. The data is presented in three panels of beeswarm plots: (a) Viral stimuli including RSV, RV1B, RV16, polyIC, R848, and CpGA; (b) T-cell stimulus PHA; and (c) Bacterial stimuli including Strpn, LTA, Hin, LPS, PAM, PGN, FSL, and Fla. The y-axis represents 'Fold induction' (response/media) on a logarithmic scale from 1/16 to 1024, with a horizontal reference line at 1. The chart tracks 28 distinct cytokines, color-coded and labeled (e.g., IFN-alpha2, IL-6, TNF, IFN-gamma, and CXCL10/IP-10). Each dot represents an individual subject (child), revealing inter-individual variability. Viral stimuli demonstrate strong induction of interferon-alpha2 and IP-10, while bacterial stimuli show potent induction of pro-inflammatory cytokines like IL-6 and TNF. PHA exhibits a distinct signature favoring T-cell cytokines like IL-2 and IFN-gamma. The diagram serves as an educational tool for comparing innate and adaptive immune signaling pathways and understanding the specificity of pathogen-associated molecular patterns (PAMPs).

A multi-panel medical illustration and data graphic exploring cell membrane-coated nanoplatforms for detoxification and viral neutralization. Panel A is a pathophysiology diagram showing a comparison between a lysed red blood cell (RBC) under alpha-toxin attack and an intact RBC protected by nanosponges. Panel B contains clinical photographs of skin lesions in a murine model, contrasting severe necrosis and discoloration from alpha-toxin against significantly reduced damage with alpha-toxin/nanosponge treatment. Panel C is a Kaplan-Meier survival plot showing improved survival rates for the nanosponge group over 360 hours. Panel D is a schematic of T-cell membrane-coated nanoparticles (TNPs) acting as decoys to intercept HIV viruses, preventing binding to host CD4 receptors. Panels E and F are bar charts showing T-cell death percentages across various treatments (PBS, RBC-NP, PEG-NP, and TNP), with TNP demonstrating a statistically significant reduction in cell death (p < 0.05 to p < 0.001). The content illustrates advanced nanomedicine strategies for treating inflammation, bacterial toxins, and viral infections.

This pathophysiology diagram illustrates the immunological mechanisms of viral-bacterial co-infection in the respiratory epithelium, specifically detailing how influenza infection predisposes the host to bacterial superinfection. The schematic shows a ciliated epithelial layer undergoing damage from influenza virions and subsequent bacterial colonization. Key innate immune responses include alveolar macrophages exhibiting increased apoptosis and decreased phagocytosis, ROS, and TLR signaling. Neutrophils show increased recruitment and NET production but impaired phagocytic capacity. The adaptive immune response is depicted with decreased activation of dendritic cells (DCs), leading to suppressed CD8+ T cell recruitment and IFN-γ production. Cytokine signaling pathways highlight a shift toward an anti-inflammatory state, characterized by increased IL-10, IFN-α/β, and IFN-λ, which inhibit Th17, γδT, and iNKT cell recruitment and their production of IL-17 and IL-22. NK cell recruitment and cytotoxicity are also downregulated. The overall pedagogical focus is on how virus-induced immune dysregulation leads to decreased bacterial clearance and increased colonization, demonstrating the complex interplay between innate and adaptive immunity during secondary infections.

This Comparison Chart illustrates the longitudinal trajectories of C-reactive protein (CRP) and plasma albumin (PA) levels in three individual patients (101, 127, 170) following a diagnosis of acute myeloid leukemia (AML). The figure consists of six subplots arranged in a 3x2 grid. The left column measures CRP levels (mg/L), representing a positive acute-phase reactant, while the right column measures plasma albumin (g/L), representing a negative acute-phase reactant. The x-axis tracks time (days) relative to AML diagnosis (Day 0, solid blue line). Key clinical milestones are marked with vertical indicators: solid blue lines for diagnosis, solid green lines for bacteraemic episodes, dashed blue lines for AML relapse, and solid black lines for death. A horizontal reference line at 35 g/L in the albumin plots indicates the threshold for hypoalbuminemia. The graphs demonstrate a typical inverse relationship during inflammatory events, such as infections or disease progression, where sharp spikes in CRP correspond to significant drops in albumin. This data is relevant for hematology and oncology, highlighting the use of these biomarkers in monitoring disease activity, infection risk, and nutritional/prognostic status in leukemia patients.

A pathophysiology flow diagram illustrating the synthesis, systemic release, and immunological functions of C-reactive protein (CRP). The pathway begins with an initial trigger, such as infection or other pathology, leading to the activation of innate immunity. The central vertical axis shows the liver as the primary site of CRP production, followed by the release of CRP (represented by a yellow pentagon) into the circulatory system. Text annotations specify that a blood concentration above 10 mg/L serves as a clinical indicator of pathology. The lower portion of the diagram branches into three distinct downstream effects: 1) Opsonization of pathogens, showing CRP bound to a green spherical target; 2) Complement activation, depicted by CRP interacting with a protein complex; and 3) Pro-inflammatory effects, specifically the activation of phagocytes (represented by a grey irregular cellular structure). This schematic summarizes CRP's role as an acute-phase reactant in human host defense and its diagnostic utility in clinical medicine.

This composite diagnostic image presents neuroimaging data analyzing the association between C-reactive protein (CRP) measures and regional brain cortical volume. It features several panels of brain surface reconstructions in lateral, dorsal, ventral, and sagittal views. Panels A and B display T-maps for Serum CRP and DNA methylation (DNAm) CRP, respectively, with a color scale from blue (-5.0) to red (5.0) representing the magnitude of association; DNAm CRP shows more widespread and intense positive associations across the frontal and temporal lobes. Panels D and E show corresponding Q-value significance maps, highlighting regions where lower cortical volume significantly correlates with inflammation. Panel C illustrates percentage attenuation when controlling for serum CRP. Panel F is a conjunction plot demonstrating the spatial overlap: pink regions indicate unique associations with serum CRP, blue regions indicate unique associations with DNAm CRP (prominent in frontal and parietal regions), and red regions show areas of shared association between both measures. This visual serves to compare stable epigenetic inflammatory markers against acute serum protein levels in the context of neurodegenerative atrophy.